Ciclesonide for the Treatment of Airway Hyperresponsiveness

NCT00826969 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Ciclesonide
DRUG: Placebo

Sponsor

AstraZeneca